{"disease":{"id":"first-line-treatment-of-adult-patients-with-metastatic-nsclc-whose-tumors-have-egfr-exon-19-deletions-or-exon-21-l858r-mutations.md","name":"first line treatment of adult patients with metastatic nsclc whose tumors have egfr exon 19 deletions or exon 21 l858r mutations.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}